Domů › Intersticiální plicní onemocnění › New York › New York City
Klinické studie Intersticiální plicní onemocnění v New York City, NY
18 studií pro Intersticiální plicní onemocnění hledá účastníky v lokalitách v New York City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Probíhá náborFáze 3
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Probíhá náborFáze 3
- Weill Cornell Medicine-New York-60569, New York
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Probíhá náborFáze 3
- USA005, New York
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Probíhá náborFáze 2
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Probíhá náborFáze 3
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Probíhá náborFáze 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Probíhá náborFáze 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Probíhá náborFáze 2
- Icahn School of Medicine at Mount Sinai, New York
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Probíhá náborFáze 3
- NYU Langone Health, New York
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Probíhá nábor
- Weill Cornell University Medical College, New York
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Probíhá náborObservační studie
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Probíhá náborObservační studie
- Weill Cornell Medicine, New York
Platform Clinical Study for Conquering Scleroderma
Probíhá náborFáze 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Probíhá náborFáze 2/3
- Columbia University Irving Medical Center, New York
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Probíhá náborObservační studie
- Weill Medical College of Cornell University, New York
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Probíhá náborFáze 3
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Probíhá náborFáze 2
- aTyr Investigative Site, New York
Studie Intersticiální plicní onemocnění v jiných městech
- Philadelphia, PA16 studií
- Los Angeles, CA14 studií
- Kansas City, KS13 studií
- Durham, NC13 studií
- Charleston, SC13 studií
- Houston, TX12 studií
- Chicago, IL12 studií
- Ann Arbor, MI11 studií
- Aurora, CO11 studií
- Salt Lake City, UT9 studií
- Rochester, MN9 studií
- Phoenix, AZ9 studií
Další studie v New York City
- Rakovina prsu137 studií
- Nemalobuněčný plicní karcinom121 studií
- Rakovina (všechny typy)110 studií
- Rakovina prostaty102 studií
- Metastatický karcinom93 studií
- Kolorektální karcinom78 studií
- Rakovina vaječníků70 studií
- Rakovina slinivky břišní60 studií
- Mnohočetný myelom60 studií
- Rakovina plic60 studií
- Rakovina endometria52 studií
- Srdeční selhání51 studií
Zdroj: ClinicalTrials.gov, data načtena 7. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.